Regeneron Pharmaceuticals, Inc… (NASDAQ:REGN)

Top Analyst Upgrades and Downgrades: Celgene, Continental Resources, Hess, Renewable Energy, US Bancorp, Zynga and Many More

Stocks were mixed on Friday despite a stronger than expected payrolls report. There are also six different Fed presidents or governors speaking on Friday, including Janet Yellen and Stanley Fischer. ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

May 4, 2017: The S&P 500 closed slightly higher on the day, up 0.06% and 1.42 points to 2,389.55. Separately the DJIA closed down 0.03% on the day at 20,951.17, ...
Read Full Story »

Jefferies Thinks 3 Red-Hot Biotech Stocks Can Beat Q1 Estimates

If any industry has been under pressure over the past year or so, it has been biotechnology. While there are some positives for the industry, it still faces some definite ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

Stocks were indicated lower on Thursday ahead of Friday's key payrolls and unemployment report. The European Central Bank maintained rates at 0.00%. Now that the bull market is officially eight years ...
Read Full Story »
automatic inspection machine

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

Almost every asset class is overbought now, and the few that aren’t — with the exception of one — have good reasons. Utilities and other income proxy stocks that were big in ...
Read Full Story »
Apple logo

Apple Named World’s Most Innovative Company

For the 11th consecutive year, Apple Inc. (NASDAQ: AAPL) has been named the world's most innovative company by The Boston Consulting Group (BCG). In nine of those years, Google/Alphabet Inc. (NASDAQ: ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: AK Steel, JC Penney, Hasbro, Petrobras, Travelers, Agilent, Regeneron and Many More

Stocks were indicated higher again on Monday after a solid week took the Dow to about 20,300 and over 2,315 on the S&P 500. Even though the bull market in nearly ...
Read Full Story »

Merrill Lynch Says 5 Companies Could Benefit Huge From Trump Tax Plan

Like him or not, one thing is for sure about President Trump: he is quickly carrying out pledges he made to supporters during the often brutal campaign. One of those ...
Read Full Story » logo

Merrill Lynch’s 4 Red-Hot Stocks to Buy With Up to 75% Upside Potential

When a market has stayed in bull market form for almost eight years, momentum investors and traders start to ask themselves, where do I look for alpha now? The question, as ...
Read Full Story »
Good heart health

Friday’s 6 Biopharma Movers That Can’t Be Ignored

There is a very positive sentiment in the health care sector considering the new Trump administration that will be taking over in just two weeks. The health care sector was ...
Read Full Story »
thumbs up and down

Key Analyst Upgrades and Downgrades for Tuesday: Alcoa, Arch Coal, Baidu, Ciena,, Vale and Many More

Stocks were indicated higher on Tuesday, with the Dow Jones Industrial Average still 50 points shy of DJIA 20,000 right after the opening bell. Stocks are challenging last week's all-time ...
Read Full Story »

Merrill Lynch Out With 11 Top Stock Ideas for 2017

The clock is ticking on 2016, and what a year it’s been. With the S&P 500 looking like it may be a double-digit winner, as it is currently up over ...
Read Full Story »

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

If any sector has had a tough go of it the past year, it has been health care, and especially biotechnology. Continued harsh rhetoric from politicians, especially the Democrats, over ...
Read Full Story »
automatic inspection machine

Regeneron Investors Cheer Q3 Earnings Beat, Eylea Growth

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third-quarter financial results before the markets opened on Friday. The company posted $3.13 in earnings per share (EPS) on $1.22 billion in revenue. ...
Read Full Story »
blue eye

Why Ocular Therapeutix Is Winning Big With Its Regeneron Collaboration

Ocular Therapeutix Inc. (NASDAQ: OCUL) shares jumped early on Thursday after a new partnership was announced with Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). Specifically, these companies will collaborate on the development ...
Read Full Story »